EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2

Abdualrahman Mohammed Abdualkader, Xiaobei Li, Yiming Yin, Chenhao Bai, Parisa Pourfarziani, Jiaheng Guan, Sora Kwon, Kyoung-Han Kim, Rami Al Batran

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci192333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Abdualrahman Mohammed Abdualkader und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Hydroxymethylglutaryl-CoA Synthase, Ketone Bodies, Mitochondria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SGLT2 inhibitors boost ketone production by directly activating a liver enzyme, revealing a new mechanism that may contribute to their heart and kidney benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsHydroxymethylglutaryl-CoA SynthaseKetone BodiesMitochondriaAnimalsHumansAllosteric RegulationSodium-Glucose Transporter 2Mice

Stichwörter der Autor:innen

DiabetesEndocrinologyFatty acid oxidationGlucose metabolismMetabolism

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHydroxymethylglutaryl-CoA SynthaseKetone BodiesSodium-Glucose Transporter 2

Autor:innen und Institutionen

  • Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada.
  • University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Abdualkader, A. M., Li, X., Yin, Y., Bai, C., Pourfarziani, P., Guan, J., Kwon, S., Kim, K. H., & Al Batran, R. (2026). SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2. Journal of Clinical Investigation. https://doi.org/10.1172/jci192333

Vancouver

Abdualkader AM, Li X, Yin Y, Bai C, Pourfarziani P, Guan J, et al. SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2. Journal of Clinical Investigation. 2026. doi:10.1172/jci192333

BibTeX
@article{Abdualkader2026,
  author = {Abdualkader, Abdualrahman Mohammed and Li, Xiaobei and Yin, Yiming and Bai, Chenhao and Pourfarziani, Parisa and Guan, Jiaheng and Kwon, Sora and Kim, Kyoung-Han and Al Batran, Rami},
  title = {SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci192333}
}
Kostenlos starten →